Clinical trial
Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a…
NCT00161837 · Alachua Government Services, Inc., Industry · Completed
Key facts
| NCT number | NCT00161837 |
|---|---|
| Title | Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004 |
| Official title | Single-blind Randomized Controlled Phase II/III Study to Investigate the Immunogenicity and Safety of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived) in Comparison to a Licensed Egg-derived Influenza Vaccine for Season 2003/2004 |
| Lead sponsor | Alachua Government Services, Inc., Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Vero Cell-derived Influenza Vaccine, Egg-derived Influenza Vaccine |
| Start date | Dec 1, 2003 |
| Completion | Jul 1, 2004 |
| First posted | Sep 13, 2005 |
| Last update posted | Oct 9, 2015 |
| Countries | Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: